Cargando…

Piezo1 in vascular remodeling of atherosclerosis and pulmonary arterial hypertension: A potential therapeutic target

Vascular remodeling (VR) is a structural and functional change of blood vessels to adapt to the changes of internal and external environment. It is one of the common pathological features of many vascular proliferative diseases. The process of VR is mainly manifested in the changes of vascular wall...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Han, He, Yu, Hong, Tianying, Bi, Cong, Li, Jing, Xia, Mingfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557227/ https://www.ncbi.nlm.nih.gov/pubmed/36247424 http://dx.doi.org/10.3389/fcvm.2022.1021540

Ejemplares similares

Glutaminolysis: A Driver of Vascular and Cardiac Remodeling in Pulmonary Arterial Hypertension
por: Mprah, Richard, et al.
Publicado: (2021)

Novel hub genes associated with pulmonary artery remodeling in pulmonary hypertension
por: Tan, Rubin, et al.
Publicado: (2022)

Melatonin Attenuates Dasatinib-Aggravated Hypoxic Pulmonary Hypertension via Inhibiting Pulmonary Vascular Remodeling
por: Wang, Rui, et al.
Publicado: (2022)

Echocardiographic Prognosis Relevance of Attenuated Right Heart Remodeling in Idiopathic Pulmonary Arterial Hypertension
por: Zhao, Qin-Hua, et al.
Publicado: (2021)

Notch3 signalling and vascular remodelling in pulmonary arterial hypertension
por: Morris, Hannah E., et al.
Publicado: (2019)

Transcription factors in the pathogenesis of pulmonary arterial hypertension—Current knowledge and therapeutic potential
por: Körbelin, Jakob, et al.
Publicado: (2023)

Association between right atrial area measured by echocardiography and prognosis among pulmonary arterial hypertension: a systematic review and meta-analysis
por: Liu, Ke, et al.
Publicado: (2020)

Vascular Remodeling in Pulmonary Arterial Hypertension: The Potential Involvement of Innate and Adaptive Immunity
por: Tobal, Rachid, et al.
Publicado: (2021)

Correlation between serum GDF-15 level and pulmonary vascular morphological changes and prognosis in patients with pulmonary arterial hypertension
por: Maimaiti, Yasenjiang, et al.
Publicado: (2023)

Use of the index of pulmonary vascular disease for predicting long-term outcome of pulmonary arterial hypertension associated with congenital heart disease
por: Chida-Nagai, Ayako, et al.
Publicado: (2023)

Autoimmunity in Pulmonary Arterial Hypertension: Evidence for Local Immunoglobulin Production
por: Shu, Ting, et al.
Publicado: (2021)

Piezo1, a novel therapeutic target to treat pulmonary arterial hypertension
por: Yang, Qifeng, et al.
Publicado: (2023)

Editorial: The molecular mechanisms and therapeutic targets of atherosclerosis
por: Gualtierotti, Roberta, et al.
Publicado: (2023)

An Overview of Circulating Pulmonary Arterial Hypertension Biomarkers
por: Santos-Gomes, Joana, et al.
Publicado: (2022)

Management of pregnant patients with pulmonary arterial hypertension
por: Zhang, Xiao, et al.
Publicado: (2022)

Mitochondrial dynamics in vascular remodeling and target-organ damage
por: Zhu, Tong, et al.
Publicado: (2023)

Sotatercept analog improves cardiopulmonary remodeling and pulmonary hypertension in experimental left heart failure
por: Joshi, Sachindra R., et al.
Publicado: (2023)

Function and Therapeutic Potential of Mesenchymal Stem Cells in Atherosclerosis
por: Li, Feifei, et al.
Publicado: (2017)

PRDX2 Protects Against Atherosclerosis by Regulating the Phenotype and Function of the Vascular Smooth Muscle Cell
por: Li, Jing, et al.
Publicado: (2021)

Endothelial-to-Mesenchymal Transition, Vascular Inflammation, and Atherosclerosis
por: Chen, Pei-Yu, et al.
Publicado: (2020)

Senescence in Vascular Smooth Muscle Cells and Atherosclerosis
por: Zha, Yiwen, et al.
Publicado: (2022)

Therapeutic targeting of mineralocorticoid receptors in pulmonary hypertension: Insights from basic research
por: Mamazhakypov, Argen, et al.
Publicado: (2023)

Circulating Interleukin-7 in Human Pulmonary Arterial Hypertension
por: Diekmann, Franziska, et al.
Publicado: (2021)

Inflammatory Mediators in Atherosclerotic Vascular Remodeling
por: Evans, Bryce R., et al.
Publicado: (2022)

Targeting Trimethylamine N-Oxide: A New Therapeutic Strategy for Alleviating Atherosclerosis
por: Jing, Lele, et al.
Publicado: (2022)

Retrospective angiographic study to determine the effect of atherosclerotic stenoses of upstream arteries on the degree of atherosclerosis in distal vascular territories
por: Rehwald, Rafael, et al.
Publicado: (2016)

Endothelial–Vascular Smooth Muscle Cells Interactions in Atherosclerosis
por: Li, Manna, et al.
Publicado: (2018)

Notopterol Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rat
por: Huang, Lin, et al.
Publicado: (2022)

Algal Polysaccharides as Therapeutic Agents for Atherosclerosis
por: Patil, Nikita P., et al.
Publicado: (2018)

Chronic Obstructive Pulmonary Disease and the Cardiovascular System: Vascular Repair and Regeneration as a Therapeutic Target
por: Karnati, Srikanth, et al.
Publicado: (2021)

Right Ventricle to Pulmonary Artery Coupling Predicts the Risk Stratification in Patients With Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
por: Lai, Jinzhi, et al.
Publicado: (2022)

Effects of oral targeted treatments in pulmonary arterial hypertension: A systematic review and meta-analysis
por: Zhu, Hui-ru, et al.
Publicado: (2022)

Differences in disease severity and prognosis of exercise-induced right-to-left shunt between idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension patients
por: Wang, Shang, et al.
Publicado: (2022)

The Long Non-coding RNA AC148477.2 Is a Novel Therapeutic Target Associated With Vascular Smooth Muscle Cells Proliferation of Femoral Atherosclerosis
por: Wang, Kangjie, et al.
Publicado: (2022)

Sex Differences, Estrogen Metabolism and Signaling in the Development of Pulmonary Arterial Hypertension
por: Sun, Yanan, et al.
Publicado: (2021)

Echocardiographic, Biochemical, and Electrocardiographic Correlates Associated With Progressive Pulmonary Arterial Hypertension
por: Zaky, Ahmed, et al.
Publicado: (2021)

Schistosome-Associated Pulmonary Arterial Hypertension: A Review Emphasizing Pathogenesis
por: Ferrari, Teresa Cristina Abreu, et al.
Publicado: (2021)

Relaxin Inhibits Ventricular Arrhythmia and Asystole in Rats With Pulmonary Arterial Hypertension
por: Martin, Brian, et al.
Publicado: (2021)

Validity of the ESC Risk Assessment in Idiopathic Pulmonary Arterial Hypertension in China
por: Gong, Su-Gang, et al.
Publicado: (2021)

Construction of a diagnostic signature and immune landscape of pulmonary arterial hypertension
por: Duo, Mengjie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ju62dc0uhe3ivtqbnovnm3s9te